middle.news
Noxopharm CEO Dr Gisela Mautner Resigns After Steering Strategic Shift
10:02am on Tuesday 14th of April, 2026 AEST
•
Biotechnology
Read Story
Noxopharm CEO Dr Gisela Mautner Resigns After Steering Strategic Shift
10:02am on Tuesday 14th of April, 2026 AEST
Key Points
Dr Gisela Mautner resigns as Noxopharm CEO and MD
Led company through strategic direction change since 2022
Successor appointment expected imminently
Noxopharm focuses on novel cancer and inflammation treatments
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Noxopharm (ASX:NOX)
OPEN ARTICLE